Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Providers Embrace US FDA REMS Integration Plan But Wary Of Another iPledge ‘Failure’
Oct 28 2022
•
By
Michael McCaughan
Patients and providers stressed that back-up plans be in place when the new REMS integration software is tested. • Source: Shutterstock
More from Drug Safety
More from Pink Sheet